Commentary: Modelling the epidemiology of hepatitis C and its complications

International Journal of Epidemiology

Volumn 32, Issue 5, 2003, Pages 725-726

  Armstrong, Gregory L ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIAMORPHINE;

HEPATITIS; MODELING;

AUSTRALIA; DEVELOPING COUNTRY; DISEASE COURSE; DISEASE TRANSMISSION; DRUG ABUSE; HEPATITIS C; HEPATITIS C VIRUS; HEROIN DEPENDENCE; HUMAN; INCIDENCE; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MATHEMATICAL MODEL; MEDICAL LITERATURE; NOTE; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; SAFETY;

HEPATITIS C, CHRONIC; HUMANS; INCIDENCE; MODELS, STATISTICAL; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 0142185450     PISSN: 03005771     EISSN: None     Source Type: Journal    
DOI: 10.1093/ije/dyg266     Document Type: Note

References (13)

1. Seeff LB. Natural history of chronic hepatitis C. Hepatology 2002;36: S35-S46.
2. Law MG, Dore GJ, Bath N et al. Modelling hepatitis C virus incidence, prevalence and long-term sequelae in Australia, 2001. Int J Epidemiol 2003;32:717-24.
3. Armstrong GL, Alter MJ, McQuillan GK, Margolis HS. The past incidence of hepatitis C virus infection: Implications for the future burden of chronic liver disease in the United States. Hepatology 2000; 31:777-82.
4. Salomon JA, Weinstein MC, Hammitt JK, Goldie SJ. Empirically calibrated model of hepatitis C virus infection in the United States. Am J Epidemiol 2002;156:761-73.
5. Wong JB, McQuillan GM, McHutchison JG, Poynard T. Estimating future hepatitis C morbidity, mortality, and costs in the United States. Am J Public Health 2000;90:1562-69.
6. Deuffic S, Buffat L, Poynard T, Valleron AJ. Modeling the hepatitis C virus epidemic in France. Hepatology 1999;29:1596-601.
7. Griffiths J, Nix B. Modeling the hepatitis C virus epidemic in France using the temporal pattern of hepatocellular carcinoma deaths. Hepatology 2002;35:709-15.
8. Frank C, Mohamed MK, Strickland GT et al. The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt, Lancet 2000;355:887-91.
9. Pybus OG, Rambaut A, Harvey PH. An integrated framework for the inference of viral population history front reconstructed genealogies. Genetics 2000;155:1429-37.
10. Tanaka Y, Hanada K, Mizokami M et al. A comparison of the molecular clock of hepatitis C virus in the United States and Japan predicts that hepatocellular carcinoma incidence in the United States will increase over the next two decades. Proc Natl Acad Sci U S A 2002;99:15584-89.
11. Yoshizawa H. Hepatocellular carcinoma associated with hepatitis C virus infection in Japan: Projection to other countries in the foreseeable future. Oncology 2002;62(Suppl.1):8-17.
12. Pybus OG, Drummond AJ, Nakano T, Robertson BH, Rambaut A. The epidemiology and iatrogenic transmission of hepatitis C virus in Egypt: a Bayesian coalescent approach. Science 2003; (In Press).
13. Hauri AM, Armstrong GL, Hutin YJ. The global burden of disease attributable to contaminated injections given in health care settings. Int J STD AIDS 2003; (In Press).